Spinal Cord Infarction (Spinal Stroke)

Clinical guidelines for managing ischemic spinal cord injuries, evaluating anterior spinal artery syndrome, owl's eye sign MRI, and reviewing perfusion pressure management and rehabilitative care.

⏱️ 5 min read

Table of Contents

🧠 Standard of Care & Symptoms

Spinal Cord Infarction, commonly referred to as a spinal stroke, is a rare form of stroke caused by a sudden reduction or blockage of blood supply to the spinal cord. It presents as an acute, vascular neurological emergency.

🧬 Diagnostics & Vascular Pathophysiology

Diagnosis requires urgent spinal MRI to identify ischemic changes and rule out compressive myelopathies, alongside vascular imaging of the aorta.

Pathophysiology of Spinal Cord Ischemia

The clinical syndrome of spinal stroke is determined by the specific vascular territory affected:

πŸ’Š Acute Perfusion & Rehabilitation

Treatment in the acute phase focuses on maintaining spinal cord blood flow. Long-term management relies on preventing complications and aggressive physical therapy.

Acute Perfusion Management

Rehabilitative & Autonomic Support

πŸ”¬ Active Clinical Trials

Clinical trials are currently evaluating spinal cord perfusion pressure targets, cerebrospinal fluid drainage protocols, and advanced rehabilitation devices.

NCT06922918: Spinal Cord Perfusion Pressure (SCPP) Optimization Study

Evaluating the efficacy of maintaining target SCPP > 70 mmHg using automated vasopressor delivery and lumbar drainage in the first 72 hours post-stroke.

Key Inclusion: Age 18 to 80, acute spinal cord infarction presenting within 12 hours of symptom onset, and baseline motor deficit.
NCT07050718: Early CSF Drainage in Aortic Surgery Ischemia

Investigating if prophylactic lumbar drain placement and CSF pressure regulation reduces the incidence of delayed paraplegia in high-risk thoracoabdominal aortic aneurysm repairs.

Key Inclusion: Age ≥ 18, scheduled for open or endovascular thoracic aortic repair, and no contraindications to lumbar puncture.
NCT07119718: Neuromuscular Electrical Stimulation (NMES) for Spinal Shock

Evaluating the impact of early NMES application on lower limb muscle mass preservation and deep vein thrombosis (DVT) prevention during the flaccid phase of spinal stroke.

Key Inclusion: Age 18 to 75, confirmed spinal cord infarction, and in the flaccid stage of spinal shock (duration less than 14 days).
Important: Browse actively recruiting clinical trials in our Clinical Trials Catalogue to find a local study.

πŸ—ΊοΈ Next Steps After Diagnosis

If you have recently suffered a Spinal Cord Infarction, establish these clinical care pathways:

  1. Undergo Aortic Evaluation: Ensure your vascular team has completed CT or MR angiography of the thoracic and abdominal aorta to rule out aortic dissection.
  2. Optimize Blood Pressure Targets: Work with your medical team to maintain your blood pressure within safe ranges, avoiding sudden drops.
  3. Initiate Deep Vein Thrombosis (DVT) Prophylaxis: Discuss antiplatelet therapy, anticoagulation, or sequential compression devices to prevent blood clots in the legs.
  4. Select a Specialized Rehabilitation Center: Transfer early to a rehabilitation facility experienced in spinal cord injury care to maximize functional recovery.

❓ Patient FAQ

Q: What is the difference between a spinal stroke and a brain stroke?
A: Both are caused by blocked blood flow (ischemia) or bleeding. A brain stroke affects the brain, causing symptoms like facial drooping, speech difficulty, and weakness on one side of the body. A spinal stroke affects the spinal cord, causing sudden back pain, weakness/paralysis on both sides of the body below the injury level, and loss of pain/temperature sensation.

Q: Can you recover from a spinal cord infarction?
A: Recovery varies. Some patients experience significant recovery of mobility and bladder control over months of rehabilitation, while others may have permanent paralysis. Early recognition, optimizing blood pressure, and early rehabilitation are the most critical factors for a positive outcome.

Get the Free 2026 Clinical AI Directory

Email us at caleb@openphr.org to receive our exclusive directory of over 150 open-source models and clinical trial databases.

Request Directory via Email